| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |